REPL::Response to SGX Queries::

Issuer & Securities

Issuer/ Manager
PHARMESIS INTERNATIONAL LTD.
Securities
PHARMESIS INTERNATIONAL LTD. - SG1BH6000003 - BFK
Stapled Security
No

Announcement Details

Announcement Title
Response to SGX Queries
Date &Time of Broadcast
08-Mar-2022 17:25:57
Status
Replacement
Supplementary Title
On Financial Statements
Announcement Reference
SG220307OTHRXOOF
Submitted By (Co./ Ind. Name)
Mr. Wu Xuedan
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the change in the box below)
Please refer to the attachment.

Due to inadvertent typographical error, the attachment (with correction highlighted in yellow) to this announcement replace the announcement released on 7 March 2022 (Reference no. SG220307OTHRXOOF).

Attachments

Related Announcements

Related Announcements

07/03/2022 17:39:32